Orthopedic Surgery · San Antonio, TX
NPI
1972546109
Since 2006
Specialty
Orthopedic Surgery
Code 207X00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
343 W Houston, #406
San Antonio, TX, 78205
Phone (210) 224-7800
Groups this clinician bills Medicare through
Medicare paid, 2024
$89K
1,238 services
Medicare patients, 2024
185
Average age 75
Drug cost, 2024
$34K
2,311 prescriptions
Company payments, 2025
$38.76
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mario A Bustamante was code J0702 (injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg), 414 times for 77 patients. In total Mario A Bustamante billed 1,238 services in 75 codes, and Medicare paid $89K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-30.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 414 | 77 | $5.42 | $2,243 |
| 99214 Office E&M - Established | Office | 237 | 118 | $76.07 | $18K |
| 20611 Joint Injection | Office | 103 | 64 | $62.54 | $6,441 |
| 99215 Office E&M - Established | Office | 86 | 64 | $116.70 | $10K |
| 73560 X-ray - Lower Extremity | Office | 57 | 34 | $21.20 | $1,208 |
| 99205 Office E&M - New | Office | 35 | 35 | $123.19 | $4,312 |
| 15271 Skin and Soft Tissue Substitutes | Facility | 35 | 33 | $30.61 | $1,071 |
| 99204 Office E&M - New | Office | 32 | 32 | $105.87 | $3,388 |
| 62323 Nerve Block Injection - Back | Office | 23 | 11 | $162.42 | $3,736 |
| 73030 X-ray - Upper Extremity | Office | 19 | 17 | $22.48 | $427 |
| 99223 Hospital E&M - Initial | Facility | 19 | 19 | $119.44 | $2,269 |
| 99213 Office E&M - Established | Office | 16 | 16 | $62.76 | $1,004 |
By year: 2022 $124K for 1,811 services; 2023 $83K for 1,193 services; 2024 $89K for 1,238 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mario A Bustamante prescribed most often to Medicare patients was Tramadol Hcl-Acetaminophen (Tramadol Hcl/Acetaminophen), with 546 prescriptions and refills. In total Mario A Bustamante wrote 2,311 Medicare prescriptions that cost $34K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tramadol Hcl-Acetaminophen Tramadol Hcl/Acetaminophen | 546 | 550 | 191 | $7,452 |
| Celecoxib Generic | 423 | 481 | 136 | $6,592 |
| Tizanidine Hcl Generic | 232 | 268 | 78 | $1,110 |
| Meloxicam Generic | 212 | 240 | 51 | $619 |
| Gabapentin Generic | 161 | 211 | 57 | $1,223 |
| Tramadol Hcl Generic | 155 | 159 | 45 | $1,636 |
| Diclofenac Sodium Generic | 147 | 175 | 68 | $7,199 |
| Cyclobenzaprine Hcl Generic | 139 | 146 | 34 | $905 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 66 | 66 | 38 | $598 |
| Methylprednisolone Generic | 30 | 30 | 25 | $244 |
| Ibuprofen Generic | 27 | 27 | Under 11 | $263 |
| Zolpidem Tartrate Generic | 25 | 41 | Under 11 | $253 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 | 22 | 18 | $225 |
| Amoxicillin Generic | 17 | 17 | Under 11 | $44.71 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 14 | 14 | Under 11 | $149 |
Brand drugs: 11 claims; generic drugs: 2,300 claims; opioid claims: 789.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mario A Bustamante $38.76 ($38.76 in general payments such as food, travel and fees) from 2 companies. The largest payer was Fidia Pharma USA Inc. with $22.1.
| Company | Payments | Amount |
|---|---|---|
| Fidia Pharma USA Inc. | 1 | $22.1 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $16.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.